Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990-1998

Gynecologic Oncology

Volumn 75, Issue 3, 1999, Pages 427-431

  Petry, Karl Ulrich ^a   Böhmer, Gerd ^a   Iftner, Thomas ^b   Flemming, Peer ^a   Stoll, Matthias ^a   Schmidt, Reinhold Ernst ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER RISK; CANCER STAGING; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX CANCER;

EID: 0344146414     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5639     Document Type: Article

References (27)

1. Bosch F X, Manos M M, Munoz N, Sherman M, Jansen A M, Peto J, Schiffman M H, Moreno V, Kurman R, Shah K V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 87:1995;796-802.
2. Jacobs, M, V, Manos, M, M, Munoz, N, Bosch, F, X, Kummer, A, Meijer, C, JLM, Shah, K, V, Snijders, P, JF, Walboomers, J, MM, Prevalence of human papillomavirus in cervical cancer: extension of the worldwide IBSCC study. Proc. 16th International Papillomavirus Conference:455, 1997, Siena, Italy, Sept 5-11, 1997, (abstract).
3. van Muyden R PCA, ter Hamsel B WA, Smedts F MM, Hermans J, Kuijpers J C, Raikhlin N T, Petrov S, Lebedev A, Ramaekers F CS, Trimbos J B, Kleter B, Quint W GV. Detection and typing of human papillomavirus in cervical carcinomas in Russian women. Cancer. 85:1999;2011-2016.
4. Macgregor J E, Campbell M K, Mann E MF, Swanson K Y. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ. 308:1994;1407-1411.
5. Koss L G. Cervical (Pap) smear. Cancer. 71:1993;1406-1412.
6. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele S T, Guillebaud J. Human papillomavirus testing in primary cervical screening. Lancet. 345:1995;1533-1536.
7. Kesic V I, Soutter W P, Sulovic V, Juznic N, Aleksic M, Ljubic A. A comparison of cytology and cervicography in cervical screening. Int J Gynecol Cancer. 3:1993;395-398.
8. Kiviat N B, Koutsky L A, Paavonen J A, Galloway D, Critchlow C, Beckmann A. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis. 159:1989;293-302.
9. Raffle A E, Alden B, Mackenzie E FD. Detection rates for abnormal cervical smears: what are we screening for? Lancet. 345:1995;1469-1473.
10. Chua K L, Hjerpe A. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer. 77:1996;121-127.
11. Walboomers J MM, de Roda Husman A M, Snijders P JF, Ste H V, Risse E KJ, Helmerhorst T JM, Voorhorst F J, Meijer C JLM. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol. 48:1995;728-732.
12. Cox J T, Lörincz A T, Schiffmann M H, Sherman M E, Cullen A, Kurman R J. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical cells of undetermined significance. Am J Obstet Gynecol. 172:1995;946-954.
13. Remink A J, Walboomers J MM, Helmerhorst T JM. The presence of persistent high risk HPV genotypes in dysplastic lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 61:1995;306-311.
14. Schneider A, Zahm D, Kirchmayr R, Schneider V. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol. 174:1996;1534-1541.
15. Lörincz, A, T, Hildesheim, A, Herrero, R, Mielzynska, I, Sherman, M, Schiffmann, M, H, Comparison of hybrid capture II HPV DNA detection and conventional Pap smear for cervical cancer screening in Costa Rica, 26, 1999, Charleston, USA. Proceedings 17th International Papillomavirus Conference (abstract).
16. Chin K M, Sidhu J S, Janssen R S, Weber J T. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients. Obstet Gynecol. 92:1998;83-87.
17. Fruchter R G, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia C D. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 87:1998;338-344.
18. Maiman M, Fruchter R G, Sedlis A, Feldman J, Chen P, Burk R D, Minkoff H. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol. 68:1998;233-238.
19. Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R D. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency-uninfected women. Am J Obstet Gynecol. 178:1998;982-986.
20. Petry K U, Scheffel D, Bode U, Gabrysiak T, Köchel H, Kupsch E, Glaubitz M, Niesert S, Kühnle H, Schedel I. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervicallesions. Int J Cancer. 57:1994;836-840.
21. Petry K U, Köchel H, Bode U, Schedel I, Niesert S, Glaubitz M, Maschek H, Kühnle H. Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women. Gynecol Oncol. 60:1996;30-34.
22. Wright T C, Ellerbrock T V, Chiasson M A, van Devanter N, Sun X W. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol. 84:1994;591-597.
23. Ho G YF, Burk R D, Klein S, Kadish A S, Chang C J, Palan P, Basu J. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 87:1995;1365-1371.
24. Sun X W, Kuhn L, Ellerbrock T V, Chiasson M A, Bush T J, Wright T C. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 337:1997;1343-1349.
25. Beral V, Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr. 23:1998;1-6.
26. Kiviat N. Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol. 175:1996;1099-1104.
27. Manos M M, Kinney W K, Hurley L B, Sherman M, Shieh-Ngai J, Kurman R, Ransley J E, Hartinger J S, McIntosh K M, Pawlick G F, Hiatt R A. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 281:1999;1605-1610.